UnitedHealth Group (NYSE:UNH) PT Raised to $590.00

UnitedHealth Group (NYSE:UNHGet Rating) had its price target boosted by Loop Capital from $575.00 to $590.00 in a report published on Tuesday, The Fly reports.

UNH has been the topic of a number of other reports. Morgan Stanley reiterated an overweight rating and issued a $587.00 target price on shares of UnitedHealth Group in a report on Wednesday, November 23rd. Royal Bank of Canada boosted their price target on shares of UnitedHealth Group from $588.00 to $592.00 and gave the company an outperform rating in a report on Monday, October 17th. SVB Leerink cut their price target on shares of UnitedHealth Group from $625.00 to $618.00 and set an outperform rating on the stock in a report on Monday, October 17th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $569.00 to $615.00 and gave the company a buy rating in a report on Tuesday, October 18th. Finally, StockNews.com started coverage on shares of UnitedHealth Group in a research report on Wednesday, October 12th. They set a strong-buy rating on the stock. Three analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of Moderate Buy and a consensus price target of $599.28.

UnitedHealth Group Stock Up 1.7 %

UNH stock opened at $484.36 on Tuesday. UnitedHealth Group has a 52 week low of $445.73 and a 52 week high of $558.10. The company has a market capitalization of $452.56 billion, a price-to-earnings ratio of 22.86, a price-to-earnings-growth ratio of 1.35 and a beta of 0.73. The firm’s 50-day moving average is $519.94 and its two-hundred day moving average is $524.48. The company has a current ratio of 0.77, a quick ratio of 0.82 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNHGet Rating) last released its earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, topping analysts’ consensus estimates of $5.17 by $0.17. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The business had revenue of $82.79 billion for the quarter, compared to the consensus estimate of $82.53 billion. During the same period in the previous year, the firm earned $4.48 EPS. The business’s revenue for the quarter was up 12.3% on a year-over-year basis. On average, analysts forecast that UnitedHealth Group will post 24.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 13th. Shareholders of record on Monday, December 5th were given a $1.65 dividend. This represents a $6.60 annualized dividend and a yield of 1.36%. The ex-dividend date of this dividend was Friday, December 2nd. UnitedHealth Group’s dividend payout ratio is 31.15%.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 616 shares of the company’s stock in a transaction on Friday, December 2nd. The shares were sold at an average price of $535.00, for a total transaction of $329,560.00. Following the completion of the sale, the executive vice president now directly owns 8,463 shares of the company’s stock, valued at approximately $4,527,705. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.40% of the stock is owned by insiders.

Institutional Trading of UnitedHealth Group

Several large investors have recently modified their holdings of the company. Quent Capital LLC boosted its holdings in shares of UnitedHealth Group by 5.1% during the 4th quarter. Quent Capital LLC now owns 3,543 shares of the healthcare conglomerate’s stock worth $1,879,000 after buying an additional 171 shares during the period. KRS Capital Management LLC grew its holdings in shares of UnitedHealth Group by 3.7% in the 4th quarter. KRS Capital Management LLC now owns 2,180 shares of the healthcare conglomerate’s stock worth $1,156,000 after purchasing an additional 77 shares during the last quarter. Asset Dedication LLC grew its holdings in UnitedHealth Group by 3.9% during the 4th quarter. Asset Dedication LLC now owns 13,327 shares of the healthcare conglomerate’s stock worth $7,125,000 after acquiring an additional 501 shares during the last quarter. Crossmark Global Holdings Inc. grew its holdings in UnitedHealth Group by 1.0% during the 4th quarter. Crossmark Global Holdings Inc. now owns 40,091 shares of the healthcare conglomerate’s stock worth $21,255,000 after acquiring an additional 389 shares during the last quarter. Finally, Catalyst Financial Partners LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at about $1,427,000. 86.31% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

The Fly logo

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.